Your browser doesn't support javascript.
loading
Postsorafenib systemic treatments for hepatocellular carcinoma: questions and opportunities after the regorafenib trial.
Tovoli, Francesco; Lorenzo, Stefania De; Barbera, Maria Aurelia; Garajova, Ingrid; Frega, Giorgio; Palloni, Andrea; Pantaleo, Maria Abbondanza; Biasco, Guido; Brandi, Giovanni.
Afiliação
  • Tovoli F; Unit of Internal Medicine, Department of Medical & Surgical Sciences, University of Bologna, Italy.
  • Lorenzo S; Unit of Oncology, Department of Experimental, Diagnostic & Specialty Medicine, University of Bologna, Italy.
  • Barbera MA; Unit of Oncology, Department of Experimental, Diagnostic & Specialty Medicine, University of Bologna, Italy.
  • Garajova I; Unit of Oncology, Department of Experimental, Diagnostic & Specialty Medicine, University of Bologna, Italy.
  • Frega G; Unit of Oncology, Department of Experimental, Diagnostic & Specialty Medicine, University of Bologna, Italy.
  • Palloni A; Unit of Oncology, Department of Experimental, Diagnostic & Specialty Medicine, University of Bologna, Italy.
  • Pantaleo MA; Unit of Oncology, Department of Experimental, Diagnostic & Specialty Medicine, University of Bologna, Italy.
  • Biasco G; 'G. Prodi' Interdepartmental Center for Cancer Research (C.I.R.C.), University of Bologna, Italy.
  • Brandi G; Unit of Oncology, Department of Experimental, Diagnostic & Specialty Medicine, University of Bologna, Italy.
Future Oncol ; 13(21): 1893-1905, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28693355

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Future Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Future Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido